We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
677

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$125M
2
AAPL icon
Apple
AAPL
+$118M
3
AMZN icon
Amazon
AMZN
+$91.8M
4
META icon
Meta Platforms (Facebook)
META
+$70.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$50.3M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$404M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$82.3M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$41.8M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$36.3M
5
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$20.5M

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLV icon
4676
Vanguard Long-Term Bond ETF
BLV
$5.69B
$9K ﹤0.01%
90
– –
BOTJ icon
4677
Bank Of The James
BOTJ
$126M
$9K ﹤0.01%
592
+233
+65% +$3.62K
BOTZ icon
4678
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.58B
$9K ﹤0.01%
264
-1,302
-83% -$48K
CHCI icon
4679
Comstock Holding Companies
CHCI
$177M
$9K ﹤0.01%
+1,977
New +$9.28K
CLLS
4680
Cellectis
CLLS
$314M
$9K ﹤0.01%
1,068
-941
-47% -$9.25K
CRWS icon
4681
Crown Crafts
CRWS
$30.5M
$9K ﹤0.01%
1,238
+428
+53% +$3.18K
DXPE icon
4682
DXP Enterprises
DXPE
$3.11B
$9K ﹤0.01%
345
-134
-28% -$4.08K
ELDN icon
4683
Eledon Pharmaceuticals
ELDN
$276M
$9K ﹤0.01%
+2,056
New +$10.4K
ELUT icon
4684
Elutia
ELUT
$40.7M
$9K ﹤0.01%
1,435
+1,254
+693% +$7.35K
ESPR
4685
DELISTED
Esperion Therapeutics
ESPR
$9K ﹤0.01%
1,880
-7,154
-79% -$57.3K
ESQ icon
4686
Esquire Financial Holdings
ESQ
$1.57B
$9K ﹤0.01%
+290
New +$9.38K
FBIO icon
4687
Fortress Biotech
FBIO
$92.3M
$9K ﹤0.01%
233
-1,479
-86% -$66K
FRST icon
4688
Primis Financial Corp
FRST
$413M
$9K ﹤0.01%
629
-550
-47% -$8.35K
GAM
4689
General American Investors Company
GAM
$1.62B
$9K ﹤0.01%
+200
New +$8.8K
GBTG icon
4690
American Express Global Business Travel
GBTG
$4.94B
$9K ﹤0.01%
900
+725
+414% +$7.13K
GCO icon
4691
Genesco
GCO
$388M
$9K ﹤0.01%
148
-2,243
-94% -$142K
GLUE icon
4692
Monte Rosa Therapeutics
GLUE
$1.33B
$9K ﹤0.01%
458
-927
-67% -$19.4K
GORV
4693
DELISTED
Lazydays
GORV
$9K ﹤0.01%
14
-18
-56% -$11.3K
GPOR icon
4694
Gulfport Energy Corp
GPOR
$3.02B
$9K ﹤0.01%
116
+10
+9% +$779
MCHB
4695
Mechanics Bancorp
MCHB
$3.79B
$9K ﹤0.01%
178
-5,712
-97% -$275K
HYMC icon
4696
Hycroft Mining Holding Corp
HYMC
$2.59B
$9K ﹤0.01%
1,416
+86
+6% +$979
IBIO icon
4697
iBio
IBIO
$70.5M
$9K ﹤0.01%
33
+21
+175% +$8.01K
ICHR icon
4698
Ichor Holdings
ICHR
$2.65B
$9K ﹤0.01%
200
-1,192
-86% -$52.8K
IGLB icon
4699
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.78B
$9K ﹤0.01%
133
– –
KALV
4700
DELISTED
KalVista Pharmaceuticals
KALV
$9K ﹤0.01%
687
-178
-21% -$2.83K
186 187
188
189 190

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 677 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.